首页 | 本学科首页   官方微博 | 高级检索  
     

2008年我院口服降糖药应用分析
引用本文:马立如,李荣. 2008年我院口服降糖药应用分析[J]. 中国医院用药评价与分析, 2009, 0(8): 593-595
作者姓名:马立如  李荣
作者单位:首都医科大学燕京医学院附属密云医院药剂科,北京市101500
摘    要:目的:了解我院口服降糖药使用现状及发展趋势。方法:对我院2008年口服降糖药的销售金额、用药频度(DDDs)、日均费用(DDC)等进行回顾性分析。结果:我院2008年口服降糖药销售金额排序前3位的是阿卡波糖、瑞格列奈、二甲双胍;DDDs排序前3位的是阿卡波糖、二甲双胍、瑞格列奈;二甲双胍的DDC最低。结论:我院口服降糖药应用基本合理,新药用量呈上升趋势,老药仍占据相当地位。

关 键 词:口服降糖药  用药频度  日均费用  用药分析

Utilization of Oral Hypoglycemic Agents in Our Hospital in 2008
MA Li-ru,LI Rong. Utilization of Oral Hypoglycemic Agents in Our Hospital in 2008[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2009, 0(8): 593-595
Authors:MA Li-ru  LI Rong
Affiliation:(Dept. of Pharmacy, The Affiliated Miyun Hospital of Yanjing Medical College of Capital Medical University, Beijing 101500, China)
Abstract:OBJECTIVE:To investigate the status quo and the trend of development of the utilization of oral hypoglycemic agents in our hospital.METHODS:The utilization of oral hypoglycemic agents in our hospital in 2008 was analyzed retrospectively in respect of the consumption sum,DDDs and drug daily cost(DDC)etc.RESULTS:The top 3 oral hypoglycemic agents in terms of consumption sum in our hospital in 2008 were acarbose,repaglinide and metformin.The top 3 oral hypoglycemic agents in terms of DDDs were acarbose,metformin and repaglinide.The DDC of metformin was the lowest.CONCLUSION:The utilization of oral hypoglycemic agents in our hospital was rational on the whole.The consumption quantity of new drugs showed an upward trend whereas the old drugs still occupied an important position.
Keywords:Oral hypoglycemic agents  DDDs  Drug daily cost  Analysis of drug use
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号